157 A transcriptomics-based response predictor identifies potential responders among patients with negative standard markers for response to immune checkpoint blockers

• Eytan Ruppin,
• Raanan Berger,
• Gal Dinstag,
• Tuvik Beker,
• Efrat Elis,
• Doreen S Ben-Zvi,
• Kenneth Aldape,
• Ranit Aharonov

Affiliations

Eytan Ruppin

Cancer Data Science Laboratory, National Cancer Institute, Bethesda, MD, USA

Raanan Berger

3Chaim Sheba Medical Center, Ramat Gan, Israel

Gal Dinstag

2 Pangea Biomed, Tel Aviv, Israel

Tuvik Beker

2 Pangea Biomed, Tel Aviv, Israel

Efrat Elis

1Pangea Biomed, Tel Aviv, Israel

Doreen S Ben-Zvi

1Pangea Biomed, Tel Aviv, Israel

Kenneth Aldape

2National Cancer Institute, Bethesda, MD, USA

Ranit Aharonov

1Pangea Biomed, Tel Aviv, Israel